This inventor holds 5 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Sapporo Holdings Limited, National University Corporation Asahikawa Medical University, Sapporo Breweries Limited. Active years: 2011-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yaizu, JP (2011)
- Shibuya-ku, JP (2014 - 2020)
- Tokyo, JP (2023)
Company Filing History:

Years Active: 2011-2023
Title: Syuichi Segawa: Innovator in Intestinal Protectants
Introduction
Syuichi Segawa is a notable inventor based in Shibuya-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of intestinal protectants. With a total of five patents to his name, Segawa's work has garnered attention in both academic and commercial sectors.
Latest Patents
Among his latest patents, Segawa has developed an intestinal tract protective agent. This innovative agent comprises a polyphosphoric acid or a pharmaceutically acceptable salt thereof as an active ingredient. His work in this area aims to enhance the protection of the intestinal tract, showcasing his commitment to improving health outcomes.
Career Highlights
Throughout his career, Syuichi Segawa has worked with prominent organizations, including Sapporo Holdings Limited and the National University Corporation Asahikawa Medical University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Segawa has had the opportunity to work alongside esteemed colleagues such as Yutaka Kohgo and Mikihiro Fujiya. These collaborations have further enriched his research and development efforts, leading to advancements in his field.
Conclusion
Syuichi Segawa's contributions to the development of intestinal protectants highlight his innovative spirit and dedication to improving health. His patents and collaborations reflect a commitment to advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile